Stay updated on Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial
Sign up to get notified when there's something new on the Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial page.

Latest updates to the Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial page
- Check6 days agoChange DetectedThe updated page shows expanded site locations and refreshed study dates, while the study arms, primary outcomes, and eligibility criteria remain unchanged. No new outcomes or major protocol changes are evident.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

- Check43 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional drug information and publications related to renal cell carcinoma. Notably, some previously listed locations and drug information have been removed.SummaryDifference15%

Stay in the know with updates to Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial page.